Editorial Comment to Nonmetastatic castration‐resistant prostate cancer treated with salvage focal brachytherapy after external beam radiotherapy

Editorial Comment to Nonmetastatic castration‐resistant prostate cancer treated with salvage focal brachytherapy after external beam radiotherapy

Bibliographic Details
Main Authors:	Yukiyoshi Hirayama, Taro Iguchi
Format:	Article
Language:	English
Published:	Wiley 2021-07-01
Series:	IJU Case Reports
Online Access:	https://doi.org/10.1002/iju5.12344

Similar Items

Nonmetastatic castration‐resistant prostate cancer treated with salvage focal brachytherapy after external beam radiotherapy
by: Soichiro Yoshida, et al.
Published: (2021-07-01)

Salvage brachytherapy for locally recurrent prostate cancer after external beam radiotherapy
by: Yasuhiro Yamada, et al.
Published: (2015-01-01)

Editorial Comment from Dr Hirayama and Dr Iguchi to Cranial nerve palsy caused by metastasis to the skull base in patients with castration‐resistant prostate cancer: Three case reports
by: Yukiyoshi Hirayama, et al.
Published: (2021-03-01)

Salvage Brachytherapy for Castration-Resistant and External Beam Radiotherapy-Resistant Local Recurrence 17 Years after Radical Prostatectomy
by: Shogo Hosogoe, et al.
Published: (2015-01-01)

High-dose-rate brachytherapy with external beam radiotherapy versus low-dose-rate brachytherapy with or without external beam radiotherapy for clinically localized prostate cancer
by: Hideya Yamazaki, et al.
Published: (2021-03-01)

Comparative cost-effectiveness of focal and total salvage 125 I brachytherapy for recurrent prostate cancer after primary radiotherapy
by: Max Peters, et al.
Published: (2016-12-01)

First experience of salvage HDR brachytherapy after prostate cancer radiotherapy
by: Juras Kišonas, et al.
Published: (2015-03-01)

Outcomes of salvage high-dose-rate brachytherapy with or without external beam radiotherapy for isolated vaginal recurrence of endometrial cancer
by: Shuhei Sekii, et al.
Published: (2017-05-01)

Survival Significance of Patients With Low Prostate-Specific Antigen and High-Grade Prostate Cancer After Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy
by: Yadong Guo, et al.
Published: (2019-07-01)

Budget impact analysis of darolutamide for treatment of nonmetastatic castration-resistant prostate cancer
by: Appukkuttan, S., et al.
Published: (2021)

Salvage Low Dose Rate Brachytherapy For Recurrent Prostate Cancer After External Beam Radiotherapy: Results From A Single Institution With Focus On Toxicity And Functional Outcomes
by: F Barbera, et al.
Published: (2017-11-01)

Deformable registration when combining brachytherapy and external beam radiotherapy
by: Mach, Lisa
Published: (2021)

Future directions of in vivo dosimetry for external beam radiotherapy and brachytherapy
by: Frank Verhaegen, et al.
Published: (2020-10-01)

Perioperative Search for Circulating Tumor Cells in Patients Undergoing Prostate Brachytherapy for Clinically Nonmetastatic Prostate Cancer
by: Hideyasu Tsumura, et al.
Published: (2017-01-01)

Pharmacoeconomic aspects of using enzalutamide for treatment of patients with nonmetastatic castration-resistant prostate cancer
by: N. A. Avxentyev, et al.
Published: (2020-07-01)

Patient and caregiver benefit‐risk preferences for nonmetastatic castration‐resistant prostate cancer treatment
by: Sandy Srinivas, et al.
Published: (2020-09-01)

Darolutamide: a novel androgen-signaling agent in nonmetastatic castration-resistant prostate cancer
by: Jeanny B Aragon-Ching
Published: (2020-01-01)

Efficacy and toxicity outcomes for patients treated with focal salvage high dose rate brachytherapy for locally recurrent prostate cancer
by: Finbar Slevin, et al.
Published: (2020-07-01)

Salvage Brachytherapy for Biochemically Recurrent Prostate Cancer following Primary Brachytherapy
by: John M. Lacy, et al.
Published: (2016-01-01)

CT-Guided 125I Seed Interstitial Brachytherapy as a Salvage Treatment for Recurrent Spinal Metastases after External Beam Radiotherapy
by: Lihong Yao, et al.
Published: (2016-01-01)

Salvage high-dose-rate brachytherapy for local prostate cancer recurrence after radical radiotherapy
by: V. A. Solodkiy, et al.
Published: (2016-12-01)

Low and high-dose-rate brachytherapy in combination with external beam radiotherapy for high risk prostate cancer
by: V. A. Solodkiy, et al.
Published: (2021-07-01)

Radical prostatectomy, external beam radiotherapy, or external beam radiotherapy with brachytherapy boost: Comparison of outcomes in a multi-institutional analysis of patients with high-risk prostate cancer
by: A.U. Kishan, et al.
Published: (2020-07-01)

Focal salvage treatment for radiorecurrent prostate cancer: A magnetic resonance-guided stereotactic body radiotherapy versus high-dose-rate brachytherapy planning study
by: Thomas Willigenburg, et al.
Published: (2020-07-01)

Brachytherapy and External Beam Radiation and Survival of Jamaicans With Prostate Cancer
by: Brown-Williams, Salome Elizabeth
Published: (2017)

Salvage brachytherapy with or without external beam radiotherapy for oral or oropharyngeal squamous cell carcinomas in previously irradiated areas: carcinologic and toxicity outcomes of 25 patients
by: Pierre-Marie Pialat, et al.
Published: (2021-08-01)

The ARAMIS trial: Why Darolutamide is better than apalutamide and enzalutamide in nonmetastatic castration-resistant prostate cancer
by: Sambit Tripathy
Published: (2021-01-01)

Salvage high-dose-rate brachytherapy for recurrent prostate cancer
by: A. D. Kaprin, et al.
Published: (2021-02-01)

Five-year quality of life in patients with high-risk localized prostate cancer treated with external beam radiotherapy alone versus external beam radiotherapy with high-dose-rate brachytherapy boost: a prospective multicenter study
by: Evelyn Martínez, et al.
Published: (2021-02-01)

High biologically effective dose radiation therapy using brachytherapy in combination with external beam radiotherapy for high-risk prostate cancer
by: Keisei Okamoto, et al.
Published: (2017-02-01)

External beam radiotherapy for localized prostate cancer
by: Hasan Yilmaz, et al.
Published: (2015-01-01)

Hypofractionated External-Beam Radiotherapy for Prostate Cancer
by: L. Chinsoo Cho, et al.
Published: (2013-01-01)

Androgen Receptor Splice Variant 7 Drives the Growth of Castration Resistant Prostate Cancer without Being Involved in the Efficacy of Taxane Chemotherapy
by: Yasuomi Shimizu, et al.
Published: (2018-11-01)

Author Correction: Comparison of Image-Guided Intensity-Modulated Radiotherapy and Low-dose Rate Brachytherapy with or without External Beam Radiotherapy in Patients with Localized Prostate Cancer
by: Takuji Tsubokura, et al.
Published: (2018-09-01)

Salvage high-dose-rate brachytherapy for local recurrence of prostate cancer
by: D. M. Yagudaev, et al.
Published: (2018-07-01)

Second salvage high-dose-rate brachytherapy for radiorecurrent prostate cancer
by: Metha Maenhout, et al.
Published: (2017-04-01)

Long-Term (10-Year) Gastrointestinal and Genitourinary Toxicity after Treatment with External Beam Radiotherapy, Radical Prostatectomy, or Brachytherapy for Prostate Cancer
by: Grant K. Hunter, et al.
Published: (2012-01-01)

Salvage high-dose-rate interstitial brachytherapy for perineal recurrence of prostate cancer after surgery and radiotherapy: a case report
by: Andrea Vavassori, et al.
Published: (2020-10-01)

Individual prognosis at diagnosis in nonmetastatic prostate cancer: Development and external validation of the PREDICT Prostate multivariable model.
by: David R Thurtle, et al.
Published: (2019-03-01)

Quality of life and results of total androgen blockade alone and with radiotherapy in the treatment of nonmetastatic prostate cancer
by: Milovanović Lela, et al.
Published: (2012-01-01)

Cannot write session to /tmp/vufind_sessions/sess_mceet85nfrf7c2rc6cd8bku593